These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33760971)

  • 21. No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic resonance imaging study of first-episode patients.
    Roiz-Santiáñez R; Ortiz-García de la Foz V; Ayesa-Arriola R; Tordesillas-Gutiérrez D; Jorge R; Varela-Gómez N; Suárez-Pinilla P; Córdova-Palomera A; Navasa-Melado JM; Crespo-Facorro B
    Psychol Med; 2015 Oct; 45(13):2861-71. PubMed ID: 26004991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder.
    Laskaris L; Mancuso S; Shannon Weickert C; Zalesky A; Chana G; Wannan C; Bousman C; Baune BT; McGorry P; Pantelis C; Cropley VL
    Brain Behav Immun; 2021 Jul; 95():299-309. PubMed ID: 33838248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use.
    Hartberg CB; Lange EH; Lagerberg TV; Haukvik UK; Andreassen OA; Melle I; Agartz I
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):37-47. PubMed ID: 29254657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.
    Molina V; Taboada D; Aragüés M; Hernández JA; Sanz-Fuentenebro J
    Schizophr Res; 2014 Sep; 158(1-3):223-9. PubMed ID: 25088730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.
    Lesh TA; Tanase C; Geib BR; Niendam TA; Yoon JH; Minzenberg MJ; Ragland JD; Solomon M; Carter CS
    JAMA Psychiatry; 2015 Mar; 72(3):226-34. PubMed ID: 25588194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced anterior cingulate cognitive activation is associated with prefrontal-temporal cortical thinning in schizophrenia.
    Schultz CC; Koch K; Wagner G; Nenadic I; Schachtzabel C; Güllmar D; Reichenbach JR; Sauer H; Schlösser RG
    Biol Psychiatry; 2012 Jan; 71(2):146-53. PubMed ID: 21967959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical thickness in regions of frontal and temporal lobes is associated with responsiveness to cognitive remediation therapy in schizophrenia.
    Penadés R; Pujol N; Catalán R; Masana G; García-Rizo C; Bargalló N; González-Rodríguez A; Vidal-Piñeiro D; Bernardo M; Junqué C
    Schizophr Res; 2016 Mar; 171(1-3):110-6. PubMed ID: 26777884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disorders.
    Oomen PP; Gangadin SS; Begemann MJH; Visser E; Mandl RCW; Sommer IEC
    Schizophr Res; 2022 Mar; 241():228-237. PubMed ID: 35176721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia.
    Wei Q; Yan W; Zhang R; Yang X; Xie S
    Ann Gen Psychiatry; 2022 Feb; 21(1):4. PubMed ID: 35144626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Cortical Structures and Cognition in Antipsychotic-Naïve Patients With First-Episode Schizophrenia: A Partial Least Squares Correlation Analysis.
    Jessen K; Mandl RCW; Fagerlund B; Bojesen KB; Raghava JM; Obaid HG; Jensen MB; Johansen LB; Nielsen MØ; Pantelis C; Rostrup E; Glenthøj BY; Ebdrup BH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 May; 4(5):444-453. PubMed ID: 30420252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
    Schizophr Res; 2012 Jan; 134(1):83-8. PubMed ID: 22048011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function.
    Pan LH; Qian M; Qu W; Tang Q; Yan Y
    Neuropsychiatr Dis Treat; 2020; 16():2891-2897. PubMed ID: 33293814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population.
    Gu Y; Vorburger R; Scarmeas N; Luchsinger JA; Manly JJ; Schupf N; Mayeux R; Brickman AM
    Brain Behav Immun; 2017 Oct; 65():150-160. PubMed ID: 28457809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
    Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
    Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral cortical thickness and gyrification changes in first-episode psychoses and multi-episode schizophrenia.
    Del Casale A; Rossi-Espagnet MC; Napolitano A; Lucignani M; Bonanni L; Kotzalidis GD; Buscajoni A; Manelfi L; Perrone V; Gualtieri I; Brugnoli R; De Pisa E; Girardi P; Romano A; Ferracuti S; Bozzao A; Pompili M
    Arch Ital Biol; 2021 Mar; 159(1):3-20. PubMed ID: 34159573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease.
    Ullah I; Awan HA; Aamir A; Diwan MN; de Filippis R; Awan S; Irfan M; Fornaro M; Ventriglio A; Vellante F; Pettorruso M; Martinotti G; Di Giannantonio M; De Berardis D
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical thickness reduction in individuals at ultra-high-risk for psychosis.
    Jung WH; Kim JS; Jang JH; Choi JS; Jung MH; Park JY; Han JY; Choi CH; Kang DH; Chung CK; Kwon JS
    Schizophr Bull; 2011 Jul; 37(4):839-49. PubMed ID: 20026559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume.
    Fillman SG; Weickert TW; Lenroot RK; Catts SV; Bruggemann JM; Catts VS; Weickert CS
    Mol Psychiatry; 2016 Aug; 21(8):1090-8. PubMed ID: 26194183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.